RecruitingNot ApplicableNCT06318806

Towards Remission and Full Recovery From Obsessive-compulsive Disorder

Towards Remission and Full Recovery From Obsessive-compulsive Disorder: Investigating the Efficacy of Inference-Based Cognitive-Behavioral Therapy When Standard Treatment Has Failed


Sponsor

Ciusss de L'Est de l'Île de Montréal

Enrollment

160 participants

Start Date

Jul 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Obsessive-compulsive disorder (OCD) is a disabling psychiatric illness that is characterized by distressing obsessional thoughts and time-consuming compulsive rituals. Exposure and Response Prevention (ERP) is a first-line psychological treatment of choice that requires patients to face their fears by being exposed to feared stimuli. This treatment has been shown to reduce symptoms in a significant proportion of patients. However, it is considered a difficult treatment and only a minority reach remission. Residual symptoms typically remain, or reappear after treatment, which is a risk for relapse. Inference-based Cognitive Behavioral Therapy (I-CBT) is a promising evidence-based treatment developed to overcome these limitations. I-CBT has already been found to be as effective as ERP and significantly more acceptable and easier to adhere to. There is also evidence that I-CBT is more effective for subgroups of patients. Consequently, the current research project is focused on improving treatments outcomes for those provide those who have previously unable to reach remission of their symptoms with ERP. Following an initial treatment with ERP, those that have been unable to reach remission, will be randomized to either I-CBT or more ERP. It is expected that I-CBT will be significantly more effective than providing patients with more of the same. In addition, the study aims to predict treatment outcome in order to be able to tell in advance which patients do not respond to ERP. The project is designed to maximize beneficial health outcomes with a stepped-care approach to treatment, but also to work towards a more personalized choice by being able to match patients in advance with the treatment that works best for them


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a treatment program aimed at achieving full remission from obsessive-compulsive disorder (OCD) — not just reducing symptoms, but helping people recover completely and return to normal life. The program is delivered online and combines therapy with regular assessments. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with OCD as your primary condition (according to DSM-5 criteria) - Your OCD symptoms score 18 or higher on a standard scale (Y-BOCS) - Your medications have been stable for at least 4-8 weeks - You are willing to keep your medications stable during the study - You are not currently in other psychological treatment - You have access to a computer or smartphone with internet **You may NOT be eligible if...** - You have a high risk of suicide or a history of suicide attempts - You have or have had psychosis or bipolar disorder - You have a significant cognitive or developmental condition - You have a substance use disorder Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPsychotherapy

Psychotherapy is a type of treatment that can help individuals experiencing mental health conditions and emotional challenges.


Locations(1)

Institut universitaire en santé mentale de Montréal

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06318806


Related Trials